Literature DB >> 10844341

[Leiomyosarcoma of the superior vena cava: diagnosis by endovascular biopsy].

R Izzillo1, S D Qanadli, F Staroz, O Dubourg, F Laborde, G Raguin, P Lacombe.   

Abstract

We report the case of a 69-year-old woman with leiomyosarcoma of the superior vena cava presenting with acute superior vena cava syndrome (SVCS). CT and MRI failed to fully characterize the endovascular process. Percutaneous endovascular biopsy, followed by metallic stent placement to treat the SVCS, confirmed the diagnosis. Symptoms resolved within 48 hours and surgical resection of the tumor was performed one month later. Unfortunately the patient died two weeks later because of intracranial hemorrhage.

Entities:  

Mesh:

Year:  2000        PMID: 10844341

Source DB:  PubMed          Journal:  J Radiol        ISSN: 0221-0363


  4 in total

1.  Percutaneous endovascular biopsy of intravascular masses: efficacy and safety in establishing pre-therapy diagnosis.

Authors:  Anastasia Pomoni; Charalampos Sotiriadis; Frédérique Gay; Anne-Marie Jouannic; Salah D Qanadli
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Leiomyosarcoma of intravascular origin--a rare tumor entity: clinical pathological study of twelve cases.

Authors:  Daniel J Tilkorn; Joerg Hauser; Andrej Ring; Ole Goertz; Ingo Stricker; Hans U Steinau; Cornelius Kuhnen
Journal:  World J Surg Oncol       Date:  2010-11-22       Impact factor: 2.754

3.  Leiomyosarcoma of the superior vena cava: Resection with vascular reconstruction - case report and review of the literature.

Authors:  Michael G Katz; Hagi Dekel; Sorin Elias; Vladimir Kravtsov; Elena Didkovsky; Lior Sasson
Journal:  Int J Angiol       Date:  2007

Review 4.  Intravascular leiomyosarcoma of the brachiocephalic region -- report of an unusual tumour localisation: case report and review of the literature.

Authors:  Daniel-Johannes Tilkorn; Marcus Lehnhardt; Jörg Hauser; Adrien Daigeler; Detlev Hebebrand; Thomas Mentzel; Hans Ulrich Steinau; Cornelius Kuhnen
Journal:  World J Surg Oncol       Date:  2008-10-27       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.